SCIENTIFIC ADVANCES

In 2007, several clinical trial results were reported that will likely change the way patients with multiple myeloma, acute promyelocytic leukemia, childhood B-cell lymphoma, and gastrointestinal stromal tumors are treated.

• Low-dose Steroid Combined with Lenalidomide Prolongs Survival Compared with High-dose Steroid for Multiple Myeloma Treatment
• Arsenic Compound Improves Survival of Adults with Uncommon Form of Leukemia
• Highly Effective, Less Toxic Therapy for Mature B-cell non-Hodgkin Lymphoma (NHL) in Children
• Imatinib Mesylate Decreases Cancer Recurrence for Patients with Primary Gastrointestinal Stromal Tumor